Everence Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Everence Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,530	Closed	-$514K	–	944
2024 Q3	$514K	Hold	5,530	–	–	0.03%	420
2024 Q2	$358	Hold	5,530	–	–	0.02%	486
2024 Q1	$367	Hold	5,530	–	–	0.02%	510
2023 Q4	$314K	Hold	5,530	–	–	0.02%	548
2023 Q3	$301	Hold	5,530	–	–	0.02%	549
2023 Q2	$348K	Hold	5,530	–	–	0.03%	468
2023 Q1	$285	Hold	5,530	–	–	0.02%	558
2022 Q4	$254	Hold	5,530	–	–	0.02%	602
2022 Q3	$280K	Hold	5,530	–	–	0.03%	534
2022 Q2	$252K	Hold	5,530	–	–	0.02%	571
2022 Q1	$257K	Buy	+5,530	New	+$247K	0.02%	612
2021 Q1	–	Sell	-5,160	Closed	-$209K	–	732
2020 Q4	$209K	Buy	+5,160	New	+$184K	0.02%	639

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Everence Capital Management's LMAT Position: Q4 2024 in Review

Everence Capital Management sold out of LeMaitre Vascular (LMAT) in Q4 2024, closing a stake of 5,530 shares — an estimated $514K sold.

Everence Capital Management first reported a position in LMAT in Q4 2020 and held it in 12 quarters. The position peaked at $514K in Q3 2024. 307 funds tracked by Wall St. Rank hold LMAT as of Q4 2024.

Everence Capital Management reported no remaining LeMaitre Vascular position as of Q4 2024 after selling out during the quarter.
Everence Capital Management sold 5,530 LeMaitre Vascular shares in Q4 2024, an estimated $514K.
Everence Capital Management first reported a position in LeMaitre Vascular in Q4 2020 and held it in 12 quarters.
Everence Capital Management's LeMaitre Vascular position peaked at $514K in Q3 2024.
307 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2024.

Based on Everence Capital Management's 13F filing for Q4 2024, filed 3 Jan 2025.